Insys Therapeutics, Inc. (NASDAQ:INSY) announced that the FDA has granted orphan drug status to its pharmaceutical cannabidiol (CBD), for the treatment of glioblastoma multiforme (GBM.V). Glioblastoma multiforme is the most common and aggressive form of malignant primary brain tumor. INSYS Therapeutics, Inc. (NASDAQ:INSY) belongs to Healthcare sector. Its net profit margin is 31.70% and weekly performance is -4.03%. On last trading day company shares ended up $34.05. INSYS Therapeutics, Inc. (NASDAQ:INSY) distance from 50-day simple moving average (SMA50) is 13.65%.
Celladon Corporation (NASDAQ:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation, today announced the closing of its underwritten public offering of 4,600,000 shares of its common stock at $9.50 per share, including 600,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares, resulting in gross proceeds from the offering of $43.7 million before deducting underwriting discounts and commissions and other offering expenses payable by Celladon. Celladon Corporation (NASDAQ:CLDN) shares decreased -1.47% in last trading session and ended the day at $11.36. CLDN return on assets is -80.70%. Celladon Corporation (NASDAQ:CLDN) quarterly performance is 43.80%.
WisdomTree Investments (NASDAQ:WETF) Insider Luciano Siracusano III unloaded 116,953 shares of the stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $11.00, for a total value of $1,286,483.00. Following the sale, the insider now directly owns 330,872 shares of the company’s stock, valued at approximately $3,639,592. On 02 September, WisdomTree Investments, Inc. (NASDAQ:WETF) shares moved up 0.17% and was closed at $11.85. WETF EPS growth in last 5 year was 27.50%. WisdomTree Investments, Inc. (NASDAQ:WETF) year to date (YTD) performance is -33.09%.
Arotech Corporation (NASDAQ:ARTX) on 14 Aug 2014 announced that its Battery and Power Systems Division recently received a production contract for an OEM in the defense sector. The current authorized contract value is $2.5 million while the total value of the contract exceeds $5 million. The work is in support of an advanced missile defense program. Arotech Corporation (NASDAQ:ARTX) ended the last trading day at $3.78. Company weekly volatility is calculated as 4.80%and price to cash ratio as 14.35. Arotech Corporation (NASDAQ:ARTX) showed a weekly performance of 2.72%.
DigitalGlobe, Inc. (NYSE:DGI) has released the first images from its WorldView-3 super-spectral, high-resolution commercial imaging satellite. WorldView-3 was successfully launched on August 13 on a United Launch Alliance-built Atlas V rocket from Vandenberg Air Force Base, California. On August 19, DigitalGlobe completed commissioning of the satellite bus and opened the door on the main telescope. DigitalGlobe, Inc. (NYSE:DGI) shares moved up 2.70% in last trading session and ended the day on $31.19. DGI Gross Margin is 74.20% and its return on assets is 0.50%. DigitalGlobe, Inc. (NYSE:DGI) quarterly performance is 2.80%.